No Data
No Data
Shengda Biotech (603079.SH): The synthetic biology platform currently has a platform for strain construction, high-throughput screening, testing and fermentation
Gelonghui, May 7 | Shengda Biotech (603079.SH) said on the investor interactive platform that the company's synthetic biology platform currently has a platform for strain construction, high-throughput screening, testing and fermentation. The “Full Biosynthesis Technology and Green Manufacturing Demonstration for Major Vitamin Products” project jointly developed by the company and Zhejiang University aims to solve the problems of using toxic chemicals and high risk levels in traditional D-biotin production processes. At present, it has passed small test verification and fermentation process optimization, and has obtained 1 invention patent.
Synthetic organisms are now differentiated! Big bulls have advanced to the 5th straight board, and policy expectations haven't been met yet?
There will be major policies in the future
Optimistic Investors Push Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) Shares Up 27% But Growth Is Lacking
Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) shares have continued their recent momentum with a 27% gain in the last month alone. Taking a wider view, although not as strong as the last month
Shengda Biotech (603079.SH): Net loss of 54.062,900 yuan in 2023
Gelonghui, April 19 | Shengda Biotech (603079.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 727 million yuan, a year-on-year decrease of 1.44%; net profit attributable to shareholders of listed companies - 54.629 million yuan; and basic earnings per share - 0.32 yuan. The company plans to distribute a cash dividend of 0.60 yuan (tax included) for every 10 shares to all shareholders.
Sunda Biotech (603079.SH): A total of 1.09% of shares have been repurchased
Gelonghui, April 1, 丨 Shengda Biotech (603079.SH) announced that by the end of March 2024, the company had repurchased a total of 1.872,500 shares through centralized bidding transactions, accounting for 1.09% of the company's total share capital. The highest purchase price was 13.38 yuan/share, the lowest price was 7.428 yuan/share, and the total amount paid was 22.784 million yuan (excluding transaction fees such as stamp duty and transaction commissions).
Sunda Biotech (603079.SH): Does not involve food preservation
Gelonghui, March 29丨Shengda Biotech (603079.SH) announced abnormal stock trading fluctuations. Recently, the company paid attention to discussions on the company's related business on some media, stock bars and other platforms, involving hot concepts such as prepared dishes. Currently, the company's main products are vitamin products such as biotin and folic acid, and biological preservative products such as streptococcin lactate, natamycin, and polylysine. According to the company's own inspection, the company currently specializes in biological preservative products, mainly used in preservative preservation of meat products, dairy products, marinated semi-dried tofu, beverages and convenience foods, etc., not in the field of prepared dishes; mainly vitamin products
No Data